Bioactive Compounds Against SARS-CoV-2

Jen-Tsung Chen editor

Format:Hardback

Publisher:Taylor & Francis Ltd

Published:26th Sep '23

£155.00

Supplier delay - available to order, but may take longer than usual.

Bioactive Compounds Against SARS-CoV-2 cover

Coronaviruses can cause illness, severe disease, and death; for example, Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and COVID-19. Vaccine development and antiviral drugs are challenged by the propensity for viral mutations allowing these viruses to evade such therapies. There are a number of bioactive compounds from natural sources, which can exert health benefits and act as antiviral therapies such as anti-inflammation, antioxidative stress, and immune regulation. This book summarizes research on the potential efficacy and underlying mechanisms of bioactive compounds and traditional medicines against SARS-CoV-2.

Key Features

  • Summarizes the potential benefits of bioactive therapies for coronaviruses
  • Focuses on COVID-19, but also covers MERS and SARS
  • Provides alternatives to vaccines and other antiviral drugs whose efficacy is reduced by viral mutations
  • Relevant for clinicians and public health officials
  • <

ISBN: 9781032347998

Dimensions: unknown

Weight: 1056g

276 pages